Association of cigarette smoking and adverse events in left ventricular assist device patients
暂无分享,去创建一个
C. Yancy | E. Vorovich | A. Anderson | J. Wilcox | R. Harap | J. Rich | D. Pham | Q. Youmans | Amy Zhou | Mickyas H Eskender | A. Ezema | K. Ghafourian | R. Ohiomoba | I. Okwuosa | Quentin R. Youmans
[1] S. Hsu,et al. Risk of left ventricular assist device driveline infection: A systematic literature review , 2019, Heart & lung : the journal of critical care.
[2] M. Mehra. The burden of haemocompatibility with left ventricular assist systems: a complex weave. , 2019, European heart journal.
[3] E. Riboli,et al. Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies , 2018, European journal of preventive cardiology.
[4] James W Long,et al. Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.
[5] S. Chaparro,et al. Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy , 2017, Open journal of cardiovascular surgery.
[6] N. Uriel,et al. Left Ventricular Assist Devices for Lifelong Support. , 2017, Journal of the American College of Cardiology.
[7] Valluvan Jeevanandam,et al. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.
[8] Robert L Kormos,et al. Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] Mohsen Naghavi,et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study , 2015, Neuroepidemiology.
[10] N. Benowitz,et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. , 2015, Journal of the American College of Cardiology.
[11] Paolo Vineis,et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. , 2015, Human molecular genetics.
[12] M. Acker,et al. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] Nader Moazami,et al. Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.
[14] F. Pagani,et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] Mohammed K. Ali,et al. Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. , 2012, Global heart.
[16] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[17] C. Dethlefsen,et al. Smoking and venous thromboembolism: a Danish follow‐up study , 2009, Journal of thrombosis and haemostasis : JTH.
[18] David Steven Scott,et al. Tobacco use increases susceptibility to bacterial infection , 2008, Tobacco induced diseases.
[19] Karen Ulisney,et al. INTERMACS database for durable devices for circulatory support: first annual report. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] Nader Moazami,et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. , 2007, The Annals of thoracic surgery.
[21] N. Benowitz,et al. Cigarette smoking and infection. , 2004, Archives of internal medicine.
[22] B. Psaty,et al. Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives. , 2002, Preventive medicine.
[23] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.
[24] K. Dracup,et al. Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions among veterans. , 2000, The American journal of cardiology.
[25] J. Manson,et al. Smoking Cessation and Time Course of Decreased Risks of Coronary Heart Disease in Middle-Aged Women , 1994 .
[26] W. Blattner,et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. , 1989, The American review of respiratory disease.
[27] I. Holme,et al. EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.